To this end we used our landscape model genes to interrogate data from the recently published Cell Line Encyclopedia [31], which includes both gene expression (Affymetrix arrays) and sensitivity (EC50) to the HER2 small molecule tyrosine kinase inhibitor lapatinib in 18 established breast cancer cell lines. This evidence concerns the gene ERBB2 and breast carcinoma.